Evidence-based solutions optimize clinical and market research activities for multiple life sciences departments. With centralized solutions and unified data, firms could explore new opportunities for efficiency, collaboration, and improved outcomes.
To weather the inevitable highs and lows in an industry that must balance profitability with product efficacy, many life sciences firms are working with new efficiencies to bolster research. According to a recent survey by Deloitte, nearly a third of life sciences companies are looking to invest in transformative technologies and digital tools to support diverse goals.2 Incorporating evidence-based clinical decision support and drug pricing analysis into business practices has potential to accelerate market strategies that are rooted in and supported by medical best practices and industry trends.
While the life sciences industry is increasingly recognizing the importance of evidence-based data and healthcare content to gain insights into how therapies and products perform in real-world settings, many organizations are limited by their ability to fully leverage insights because much of their data is fragmented or siloed.3 With enterprise-wide or department-wide access to the latest evidence and analytic tools, key life sciences functions would be able to increase efficiency and enhance decision-making processes to improve both business and patient outcomes.
